Karen Smith
Fortune : 216 520 $ au 31/05/2026
Fortune : 216 520 $ au 31/05/2026
Le Dr Karen L. Smith est médecin en chef chez Emergent BioSolutions, Inc. et directrice indépendante chez Antares Pharma, Inc. et Sangamo Therapeutics, Inc. et directrice indépendante chez Acceleron Pharma, Inc. Elle est membre du conseil d'administration d'Antares Pharma, Inc. et de Sangamo Therapeutics, Inc. et d'Acceleron Pharma, Inc. Le Dr Smith a été précédemment employée en tant que présidente et directrice générale de Medeor Therapeutics, Inc. et directrice générale d'Eliminate Cancer, Inc. et directrice et vice-présidente de Celator Pharmaceuticals, Inc, directeur non exécutif chez Forward Pharma A/S, directeur médical et vice-président exécutif de la recherche et du développement chez Jazz Pharmaceuticals Plc, vice-président principal des affaires médicales mondiales et chef de la dermatologie chez Allergan, Inc., chef des relations médicales externes chez AstraZeneca LP, chef des opérations cliniques aux États-Unis chez Bristol Myers Squibb Co. et directeur général chez Boron Molecular Ltd. Elle a également siégé au conseil d'administration de Sucampo Pharmaceuticals, Inc. Elle a obtenu un diplôme de premier cycle à l'université de technologie de Curtin, un diplôme d'études supérieures à l'université de Salford, un MBA à l'université de New England (Australie), un doctorat à l'université de Warwick et un doctorat à l'université de Western Australia.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 12/04/2025 | 12 672 ( 0,01 % ) | 194 262 $ | 31/05/2026 | |
| 12/06/2025 | 102 100 ( 0,02 % ) | 22 258 $ | 31/05/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 13/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Directeur/Membre du Conseil | 28/06/2018 |
| EMYRIA LIMITED | Directeur/Membre du Conseil | 29/11/2021 |
| SKYE BIOSCIENCE, INC. | Directeur/Membre du Conseil | 02/07/2024 |
| CONTEXT THERAPEUTICS INC. | Directeur/Membre du Conseil | 04/09/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| TOUE BIOPAR | Directeur/Membre du Conseil | 01/10/2023 |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Directeur Technique/Scientifique/R&D | 01/09/2023 |
| QUINCE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/09/2023 |
| ANTARES PHARMA, INC. | Directeur/Membre du Conseil | 24/05/2022 |
| EMERGENT BIOSOLUTIONS INC. | Directeur Technique/Scientifique/R&D | 01/12/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 31 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Antares Pharma, Inc.
Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops parenteral pharmaceutical products | Health Technology |
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company which develops protein therapeutics for cancer and orphan diseases | Health Technology |
Celator Pharmaceuticals, Inc.
Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
University of Salford
University of Salford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boron Molecular Ltd.
Boron Molecular Ltd. Chemicals: Major DiversifiedProcess Industries Produces and distributes chemicals and compounds to the pharmaceutical and biotechnology industries | Process Industries |
Emergent BioSolutions, Inc.
Emergent BioSolutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Sucampo Pharmaceuticals LLC
Sucampo Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures prostone based pharmaceuticals products | Health Technology |
University of Warwick
University of Warwick Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of New England (Australia)
University of New England (Australia) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Pharma A/S
Forward Pharma A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures proprietary formulations for inflammatory and neurological indications | Health Technology |
Humanetics Corp.
Humanetics Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes oncology, inflammatory diseases & biodefense drugs | Health Technology |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
Jazz Pharmaceuticals Plc
Jazz Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of pharmaceutical products to treat neurological disorders | Health Technology |
Aurinia Pharmaceuticals, Inc.
Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Quince Therapeutics, Inc.
Quince Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops drugs for the treatment of central nervous system disorders and Alzheimer’s diseases | Health Technology |
Skye Bioscience, Inc.
Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Talaris Therapeutics, Inc.
Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Medeor Therapeutics, Inc.
Medeor Therapeutics, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for organ transplant recipients | Health Technology |
Curtin University of Technology
Curtin University of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Emyria Ltd.
Emyria Ltd. Packaged SoftwareTechnology Services Develops patient-centric care model technology | Technology Services |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug to reduce complications from a broken bone due to a fall | Health Technology |
Eliminate Cancer, Inc. | |
Context Therapeutics, Inc.
Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
Mariana Oncology, Inc.
Mariana Oncology, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer | Health Technology |
Capstan Therapeutics, Inc.
Capstan Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops targeted in vivo RNA technologies | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national